Kanaya S, Katoh H
Second Department of Surgery, Hokkaido University School of Medicine, Sapporo, Japan.
Surgery. 1995 Jul;118(1):29-35. doi: 10.1016/s0039-6060(05)80006-6.
This study was aimed at evaluating advantages of distal splenorenal shunt (DSRS) with splenopancreatic and gastric disconnection (DSRS-SPGD) over DSRS with splenopancreatic disconnection (DSRS-SPD) and standard DSRS (S-DSRS).
DSRS-SPGD, DSRS-SPD, and S-DSRS were performed on 62, 7, and 55 patients, respectively, from 1970 to 1992. Comparison was performed in the following aspects: (1) long-term results in ratio of rebleeding, survival rate, and quality of life and (2) portal hemodynamics evaluated by preoperative and postoperative angiography. Portal blood flow was assessed by the ratio of the diameter of portal vein (PV) to superior mesenteric vein (SMV), and shunt selectivity was evaluated by selectivity grade.
Incidence of rebleeding was significantly lower in patients who underwent DSRS-SPGD than in those who underwent S-DSRS (p < 0.05). Grade 0 and I performance status was better in patients who underwent DSRS-SPGD. Accumulated survival ratio for 5 and 7 years was 78.3% and 70.5% in patients who underwent DSRS-SPGD, 59.7% and 44.1% in patients who underwent S-DSRS, and 75% and 75% in patients who underwent DSRS-SPD. Hemodynamic evaluation showed significantly lower PV/SMV ratio and degree of change in PV/SMV ratio of patients who underwent S-DSRS and DSRS-SPD. Many patients who underwent S-DSRS and DSRS-SPD exhibited loss of shunt selectivity at grades II and III. In contrast, patients who underwent DSRS-SPGD maintained satisfactory PV/SMV ratio and selectivity grade.
DSRS-SPGD clearly showed advantages in decrease of rebleeding and improvement of quality of life resulting from maintenance of shunt selectivity and portal blood flow.
本研究旨在评估脾胰胃离断的远端脾肾分流术(DSRS-SPGD)相对于脾胰离断的远端脾肾分流术(DSRS-SPD)和标准远端脾肾分流术(S-DSRS)的优势。
1970年至1992年期间,分别对62例、7例和55例患者实施了DSRS-SPGD、DSRS-SPD和S-DSRS。从以下方面进行比较:(1)再出血率、生存率和生活质量方面的长期结果;(2)术前和术后血管造影评估门静脉血流动力学。通过门静脉(PV)与肠系膜上静脉(SMV)直径之比评估门静脉血流,通过分流选择性分级评估分流选择性。
接受DSRS-SPGD的患者再出血发生率显著低于接受S-DSRS的患者(p<0.05)。接受DSRS-SPGD的患者0级和I级功能状态更好。接受DSRS-SPGD的患者5年和7年累计生存率分别为78.3%和70.5%,接受S-DSRS的患者为59.7%和44.1%,接受DSRS-SPD的患者为75%和75%。血流动力学评估显示,接受S-DSRS和DSRS-SPD的患者PV/SMV比值及PV/SMV比值变化程度显著更低。许多接受S-DSRS和DSRS-SPD的患者在II级和III级出现分流选择性丧失。相比之下,接受DSRS-SPGD的患者维持了令人满意的PV/SMV比值和选择性分级。
DSRS-SPGD在减少再出血以及通过维持分流选择性和门静脉血流改善生活质量方面明显显示出优势。